Clinical Trial Update: Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES) [NA]

View source ↗

Summary

A completed clinical trial update for ranibizumab in macular edema due to branch retinal vein occlusion (RABAMES).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Branch Retinal Vein Occlusion
• Macular Edema

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Klinikum Ludwigshafen | Conditions: Macular Edema | NA | Status: COMPLETED